Cantourage Group SE

News

11.03.2025 09:11:22
Original-Research: Cantourage Group SE (von NuWays AG): Buy
27.01.2025 09:01:01
Original-Research: Cantourage Group SE (von NuWays AG): Buy
15.01.2025 07:30:09
EQS-News: Legalization of cannabis brings strong growth: Cantourage Group SE increases its sales by 118% to EUR 51.4 million in full year 2024
20.12.2024 09:01:02
Original-Research: Cantourage Group SE (von NuWays AG): Buy
19.12.2024 08:00:19
EQS-News: Cantourage Group SE exports medical craft cannabis for the first time to the growth market of Poland; cooperation with the wholesaler PharmaVitae to be expanded in 2025
06.12.2024 09:01:01
Original-Research: Cantourage Group SE (von NuWays AG): BUY
20.11.2024 08:00:21
EQS-News: New Sales Record: Cantourage Group SE Reports EUR 5.5 Million in Revenue for October 2024, Reaffirming Full-Year Growth Targets
07.11.2024 08:00:16
EQS-News: Strong EBITDA growth: Cantourage Group SE posts EBITDA of EUR 1.4 million in third quarter of 2024 and sets course for further profitable growth
10.10.2024 09:02:11
Original-Research: Cantourage Group SE (von NuWays AG): Buy
10.10.2024 08:00:20
EQS-News: The medical cannabis market is booming: Cantourage Group SE reports record quarter in third quarter of 2024

Downloads

Latest Research
Initiation

Analyst

Christian Sandherr

Equity Research

MailLinkedIn

Latest Research

Christian Sandherr

11 Mar 25

Q1 on track to hit a new record

Update
Christian Sandherr

27 Jan 25

FY24 with explosive growth // new high(t)s in sight; PT Up

Update
Christian Sandherr

20 Dec 24

Cantourage entering the Polish market; PT up

Update
Christian Sandherr

06 Dec 24

Full steam ahead, FY24 guidance raised; PT up

Update
Christian Sandherr

10 Oct 24

9M prelims: Growth further accelerating, FY guidance specified

Preview / Review

Best-in-class research on selected German and European small caps. Immediately at publication and 100% free of charge.

To learn how we process your data, visit our Privacy Notice.